Stay updated on SKI-G-801 Dose Study in AML Clinical Trial
Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.

Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe revision tag on the page was updated from v3.5.3 to v3.5.4, indicating a newer version of the study record. This reflects non-substantive edits or metadata updates to the page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe revision label was updated from v3.5.2 to v3.5.3, indicating a minor update to the page's metadata. This reflects a small, non-substantive update to the ClinicalTrials.gov entry.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page's revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check62 days agoChange DetectedThe record was updated in 2024 with a new last update date and QC status; no changes to the core study design, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.5.0 has been added and v3.4.3 has been removed.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.